The stock of Mallinckrodt PLC (NYSE:MNK) is a huge mover today! About 4.41M shares traded hands or 172.22% up from the average. Mallinckrodt PLC (NYSE:MNK) has risen 15.07% since April 14, 2016 and is uptrending. It has outperformed by 10.38% the S&P500.
The move comes after 8 months negative chart setup for the $6.65 billion company. It was reported on Nov, 16 by Barchart.com. We have $56.90 PT which if reached, will make NYSE:MNK worth $532.00 million less.
Analysts await Mallinckrodt PLC (NYSE:MNK) to report earnings on November, 28. They expect $2.25 EPS, up 22.28% or $0.41 from last year’s $1.84 per share. MNK’s profit will be $241.92 million for 6.87 P/E if the $2.25 EPS becomes a reality. After $2.20 actual EPS reported by Mallinckrodt PLC for the previous quarter, Wall Street now forecasts 2.27% EPS growth.
Mallinckrodt PLC (NYSE:MNK) Ratings Coverage
Out of 15 analysts covering Mallinckrodt (NYSE:MNK), 12 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 80% are positive. Mallinckrodt has been the topic of 31 analyst reports since August 5, 2015 according to StockzIntelligence Inc. The firm earned “Outperform” rating on Wednesday, October 7 by Leerink Swann. The firm has “Outperform” rating by BMO Capital Markets given on Wednesday, June 29. The firm has “Buy” rating given on Wednesday, August 31 by Deutsche Bank. As per Thursday, July 21, the company rating was maintained by Mizuho. The firm has “Outperform” rating by Oppenheimer given on Wednesday, August 5. The stock of Mallinckrodt PLC (NYSE:MNK) has “Outperform” rating given on Wednesday, November 11 by Northland Capital. The stock of Mallinckrodt PLC (NYSE:MNK) earned “Overweight” rating by Barclays Capital on Tuesday, October 13. The company was maintained on Wednesday, August 5 by Barclays Capital. The company was upgraded on Thursday, December 3 by Morgan Stanley. The stock of Mallinckrodt PLC (NYSE:MNK) earned “Neutral” rating by JP Morgan on Wednesday, May 4.
According to Zacks Investment Research, “Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.”
Insitutional Activity: The institutional sentiment increased to 0.83 in 2016 Q2. Its up 0.07, from 0.76 in 2016Q1. The ratio increased, as 45 funds sold all Mallinckrodt PLC shares owned while 146 reduced positions. 45 funds bought stakes while 113 increased positions. They now own 100.83 million shares or 4.32% less from 105.38 million shares in 2016Q1.
Moreover, Camarda Finance Advsrs Ltd Liability Corporation has 0% invested in Mallinckrodt PLC (NYSE:MNK) for 10 shares. Meeder Asset Management Inc holds 0% of its portfolio in Mallinckrodt PLC (NYSE:MNK) for 515 shares. Suntrust Banks holds 31,756 shares or 0.01% of its portfolio. Pacad Limited holds 0.22% or 25,581 shares in its portfolio. Fincl Bank Of America Corp De accumulated 0.01% or 582,747 shares. Dreman Value L L C, a Florida-based fund reported 4,448 shares. Cambridge Investment Rech Inc has invested 0.01% of its portfolio in Mallinckrodt PLC (NYSE:MNK). First Tru Advsrs Lp owns 316,224 shares or 0.06% of their US portfolio. Credit Agricole S A holds 187,856 shares or 0.04% of its portfolio. Mark Sheptoff Financial Planning Ltd Liability Corporation has invested 0% of its portfolio in Mallinckrodt PLC (NYSE:MNK). Edge Wealth Mngmt Limited Liability Co reported 50 shares or 0% of all its holdings. Guggenheim Cap has invested 0.12% of its portfolio in Mallinckrodt PLC (NYSE:MNK). The Ontario – Canada-based Canada Pension Plan Inv Board has invested 0.01% in Mallinckrodt PLC (NYSE:MNK). Parkside Natl Bank Trust has 0.01% invested in the company for 192 shares. American Intll Gru owns 40,292 shares or 0% of their US portfolio.
More recent Mallinckrodt PLC (NYSE:MNK) news were published by: Prnewswire.com which released: “Mallinckrodt plc to Change Fiscal Year” on May 18, 2016. Also Prnewswire.com published the news titled: “Mallinckrodt plc Reports Fiscal 2016 Third Quarter Results and Provides …” on August 02, 2016. Prnewswire.com‘s news article titled: “Mallinckrodt plc To Report Fourth Quarter And Full-Year Fiscal 2016 Results …” with publication date: October 18, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.